ArticleCellular oncology (Dordrecht, Netherlands)2022

AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis.

Pradeepa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.